Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Irreversible electroporation plus allogenic Vγ9Vδ2 T cells enhances antitumor effect for locally advanced pancreatic cancer patients
Mao Lin, Xiaoyan Zhang, Shuzhen Liang, et al.
Signal Transduction and Targeted Therapy (2020) Vol. 5, Iss. 1
Open Access | Times Cited: 72

Showing 1-25 of 72 citing articles:

Gamma Delta T-Cell Based Cancer Immunotherapy: Past-Present-Future
José Saura‐Esteller, Milon de Jong, Lisa A. King, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 130
Preoperative chemotherapy, radiotherapy and surgical decision-making in patients with borderline resectable and locally advanced pancreatic cancer
Thomas F. Stoop, Rutger T. Theijse, Leonard W. F. Seelen, et al.
Nature Reviews Gastroenterology & Hepatology (2023) Vol. 21, Iss. 2, pp. 101-124
Closed Access | Times Cited: 60
Pancreatic Cancer and Immunotherapy: A Clinical Overview
Florentine E. F. Timmer, Bart Geboers, Sanne Nieuwenhuizen, et al.
Cancers (2021) Vol. 13, Iss. 16, pp. 4138-4138
Open Access | Times Cited: 95
Local Release of TGF‐β Inhibitor Modulates Tumor‐Associated Neutrophils and Enhances Pancreatic Cancer Response to Combined Irreversible Electroporation and Immunotherapy
Huiming Peng, Jian Shen, Xin Long, et al.
Advanced Science (2022) Vol. 9, Iss. 10
Open Access | Times Cited: 57
Irreversible Electroporation: An Emerging Immunomodulatory Therapy on Solid Tumors
Nana Zhang, Zhuoqun Li, Xuan Han, et al.
Frontiers in Immunology (2022) Vol. 12
Open Access | Times Cited: 44
Electroporation and Immunotherapy—Unleashing the Abscopal Effect
Tobias Freyberg Justesen, Adile Orhan, Hans Raskov, et al.
Cancers (2022) Vol. 14, Iss. 12, pp. 2876-2876
Open Access | Times Cited: 42
Amplifying “eat me signal” by immunogenic cell death for potentiating cancer immunotherapy
Yong Xi, Lijie Chen, Jian Tang, et al.
Immunological Reviews (2023) Vol. 321, Iss. 1, pp. 94-114
Closed Access | Times Cited: 38
Interventional hydrogel microsphere vaccine as an immune amplifier for activated antitumour immunity after ablation therapy
Xiaoyu Liu, Yaping Zhuang, Wei Huang, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 34
A close look at current γδ T-cell immunotherapy
Ling Ma, Yanmin Feng, Zishan Zhou
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 28
Gamma/delta T cells as cellular vehicles for anti-tumor immunity
Chelsia Qiuxia Wang, Pei Yu Lim, Andy Hee‐Meng Tan
Frontiers in Immunology (2024) Vol. 14
Open Access | Times Cited: 13
Beyond CAR T cells: exploring alternative cell sources for CAR-like cellular therapies
Christina Angeliki Tsiverioti, Adrian Gottschlich, Marcel P. Trefny, et al.
Biological Chemistry (2024) Vol. 405, Iss. 7-8, pp. 485-515
Open Access | Times Cited: 8
Advancements in the application of ablative therapy and its combination with immunotherapy in anti-cancer therapy
Luhong Wang, Yiyi Jiang, Chaoyue Sun, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2025) Vol. 1880, Iss. 2, pp. 189285-189285
Closed Access | Times Cited: 1
Research progress in inducing immunogenic cell death of tumor cells
Deqian Xie, Qifei Wang, Guangzhen Wu
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 37
Pancreatic Cancer: Challenges and Opportunities in Locoregional Therapies
Alaa Y. Bazeed, Candace M. Day, Sanjay Garg
Cancers (2022) Vol. 14, Iss. 17, pp. 4257-4257
Open Access | Times Cited: 32
Human γδ T Cell Subsets and Their Clinical Applications for Cancer Immunotherapy
Derek Lee, Carl J. Rosenthal, Natalie E. Penn, et al.
Cancers (2022) Vol. 14, Iss. 12, pp. 3005-3005
Open Access | Times Cited: 31
Irreversible Electroporation in Pancreatic Cancer—An Evolving Experimental and Clinical Method
Agnieszka Gajewska-Naryniecka, Urszula Szwedowicz, Zofia Łapińska, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 5, pp. 4381-4381
Open Access | Times Cited: 18
Umbilical cord blood derived cellular therapy: advances in clinical development
Jiasheng Wang, Leland Metheny
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 16
Photodynamic Therapy and Hyperthermia in Combination Treatment—Neglected Forces in the Fight against Cancer
Aleksandra Bienia, Olga Wiecheć-Cudak, Aleksandra Anna Murzyn, et al.
Pharmaceutics (2021) Vol. 13, Iss. 8, pp. 1147-1147
Open Access | Times Cited: 36
Local γδ T cells: translating promise to practice in cancer immunotherapy
Iva Zlatareva, Yin Wu
British Journal of Cancer (2023) Vol. 129, Iss. 3, pp. 393-405
Open Access | Times Cited: 14
An electro-ferroptotic nanoammunition enables image-guided, spatiotemporally controlled cancer ferroptosis induction via irreversible electroporation
Jun‐Hyeok Han, Hee Seung Seo, Jiyoung Lee, et al.
Chemical Engineering Journal (2024) Vol. 487, pp. 150366-150366
Closed Access | Times Cited: 5
The Current Landscape of Clinical Trials for Immunotherapy in Pancreatic Cancer: A State-of-the-Art Review
Zouina Sarfraz, Azza Sarfraz, Muhammad Farooq, et al.
Journal of Gastrointestinal Cancer (2024) Vol. 55, Iss. 3, pp. 1026-1057
Closed Access | Times Cited: 5
Co-inhibition of RAGE and TLR4 sensitizes pancreatic cancer to irreversible electroporation in mice by disrupting autophagy
Cuifang Ye, Jiangping Wu, Linrong Li, et al.
Acta Pharmacologica Sinica (2025)
Closed Access
Pulsed field ablation in medicine: irreversible electroporation and electropermeabilization theory and applications
Edward J. Jacobs, Boris Rubinsky, Rafael V. Davalos
Radiology and Oncology (2025) Vol. 59, Iss. 1, pp. 1-22
Open Access
Gamma delta T cells and their immunotherapeutic potential in cancer
Stephen G. Cieslak, Reza Shahbazi
Biomarker Research (2025) Vol. 13, Iss. 1
Open Access
The clinical landscape of CAR-engineered unconventional T cells
Yan-Ruide Li, Yichen Zhu, Yuning Chen, et al.
Trends in cancer (2025)
Open Access
Page 1 - Next Page

Scroll to top